Skip to content

← All news

Markets

Chief global commercialization officer Mancini sells $347,402 of RVMD stock

1 source ·2 articles ·Sep 22, 22:32 UTC Revolution Medicines

Covered by 1 outlet

All coverage · 2 articles

Investing.com UK ·Sep 22, 22:32 UTC

Chief global commercialization officer Mancini sells $347,402 of RVMD stock

Investing.com News ·Sep 22, 22:31 UTC

Chief global commercialization officer Mancini sells $347,402 of RVMD stock